TELA Bio, Inc.
TELA- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001561921
In the last 90 days, TELA Bio, Inc. insiders filed 4 open-market purchases and 0 sales; 45 institutions reported holding it in 13F filings for Q2 2026, worth $19.3M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by TELA Bio, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 4 filings
- 2 insiders, $186.0K in total
- Open-market sells
- 0 filings
- Insiders trading
- 2
- Net value
- +$186.0K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for TELA Bio, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Capper Joseph H | Director | 179,827 | Sep 18, 2026 | 4 |
| Getz Heather C | Chief Executive Officer | 532,500 | Aug 19, 2026 | 3 |
| Plovanic William J. | Director | 44,530 | Jul 17, 2026 | 3 |
| Thomas Paul | Director | 23,600 | Jun 11, 2026 | 1 |
| Nohra Guy P | Director | 23,600 | Jun 11, 2026 | 1 |
| Neels Guido J | Director | 23,600 | Jun 11, 2026 | 1 |
| Rocchio Betty Jo | Director | 23,600 | Jun 11, 2026 | 2 |
| Koblish Antony | Chief Executive Officer | 586,210 | Feb 24, 2026 | 1 |
| Cuca Roberto | COO and CFO | 257,377 | Feb 24, 2026 | 1 |
| Talmo Paul | Chief Technology Officer | 173,436 | Feb 24, 2026 | 1 |
| Smeykal Megan | Chief Accounting Officer | 66,873 | Feb 24, 2026 | 1 |
| Firestone Gregory A. | Chief Business Officer | 139,307 | Feb 24, 2026 | 1 |
| Blizard Jeffrey | President | 205,125 | Feb 24, 2026 | 1 |
| Ew Healthcare Partners Fund 2, L.P. | 10% Owner, Other: See Remarks | 7,714,709 | Nov 17, 2025 | 1 |
| Ew Healthcare Partners Fund 2-A, L.P. | 10% Owner, Other: See Remarks | 7,714,709 | Nov 17, 2025 | 1 |
| EW Healthcare Partners Fund 2 GP, L.P. | 10% Owner, Other: See Remarks | 7,714,709 | Nov 17, 2025 | 1 |
| EW Healthcare Partners Fund 2-UGP, LLC | 10% Owner, Other: See Remarks | 7,714,709 | Nov 17, 2025 | 1 |
| O'Brien Federica F. | Director | 18,470 | May 30, 2025 | 0 |
| Colleran Lisa N | Director | 18,470 | May 30, 2025 | 0 |
| Evans Douglas G | Director | 18,470 | May 30, 2025 | 0 |
| Burgess Vincent J | Director | 23,330 | May 30, 2025 | 0 |
| Azarbarzin Kurt | Director | 18,470 | May 30, 2025 | 0 |
| OrbiMed Advisors LLC | 10% Owner | 2,407,242Indirect | Jul 2, 2024 | 0 |
| OrbiMed Capital GP IV LLC | 10% Owner | 2,407,242Indirect | Jul 2, 2024 | 0 |
| Murphy Peter C. | Chief Commercial Officer | 48,129 | Apr 2, 2024 | 0 |
| Nosenzo John | Director | 6,270 | Jun 2, 2023 | 0 |
| Opaleye Management Inc. | Other: Former 10% Owner. | 124,813Indirect | Apr 20, 2023 | 0 |
| Quaker BioVentures II LP | 10% Owner | 0 | Jun 23, 2022 | 0 |
| Quaker BioVentures Capital II, L.P. | 10% Owner | 0 | Jun 23, 2022 | 0 |
| Greenhalgh Ellis Skott | Chief Technology Officer | 27,826 | Feb 28, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2022 (view filing)6:11 PM ET | Jun 13-15 | 2 days | Ew Healthcare Partners Fund 2, L.P. and 3 othersOther: See footnote 2 | PPurchaseCommon Stock, par value $0.001 per share | +15.0K | $5.86 | +$87.8K | +0.4%3.52M after | 3 lots |
| Jun 21, 2022 (view filing)6:43 PM ET | Jun 16-21 | 5 days | Ew Healthcare Partners Fund 2, L.P. and 3 othersOther: See footnote 2 | PPurchaseCommon Stock, par value $0.001 per share | +15.0K | $6.14 | +$92.2K | +0.4%3.53M after | 3 lots |
| Jun 22, 2022 (view filing) | Jun 10-22 | 12 daysLate | Opaleye Management Inc.10% Owner | PPurchaseCommon Stock, par value $0.001 per share | +52.4K | $6.50 | +$340.6K | +116.4%97.4K after | 2 lots |
| Jun 24, 2022 (view filing) | Jun 22 | 2 days | Opaleye Management Inc.10% Owner | PPurchaseCommon Stock, par value $0.001 per share | +2.40K | $6.99 | +$16.8K | +2.5%97.8K after | 2 lots |
| Jun 24, 2022 (view filing)7:06 PM ET | Jun 22-24 | 2 days | Ew Healthcare Partners Fund 2, L.P. and 3 othersOther: See footnote 2 | PPurchaseCommon Stock, par value $0.001 per share | +15.0K | $6.84 | +$102.6K | +0.4%3.55M after | 3 lots |
| Jun 29, 2022 (view filing)6:13 PM ET | Jun 27-28 | 2 days | Ew Healthcare Partners Fund 2, L.P. and 3 othersOther: See footnote 2 | PPurchaseCommon Stock, par value $0.001 per share | +15.0K | $7.14 | +$107.0K | +0.4%3.56M after | 3 lots |
| Jun 30, 2022 (view filing) | Jun 29-30 | 1 day | Opaleye Management Inc.10% Owner | PPurchaseCommon Stock, par value $0.001 per share | +3.57K | $7.00 | +$25.0K | +3.8%98.4K after | 3 lots |
| Jul 5, 2022 (view filing) | Jul 1 | 4 days | Opaleye Management Inc.10% Owner | PPurchaseCommon Stock, par value $0.001 per share | +200 | $7.00 | +$1.40K | +0.2%98.6K after | |
| Jul 5, 2022 (view filing)7:37 PM ET | Jun 30-Jul 5 | 5 days | Ew Healthcare Partners Fund 2, L.P. and 3 othersOther: See footnote 2 | PPurchaseCommon Stock, par value $0.001 per share | +15.0K | $7.29 | +$109.3K | +0.4%3.58M after | 3 lots |
| Jul 8, 2022 (view filing)5:58 PM ET | Jul 6-8 | 2 days | Ew Healthcare Partners Fund 2, L.P. and 3 othersOther: See footnote 2 | PPurchaseCommon Stock, par value $0.001 per share | +15.0K | $7.96 | +$119.5K | +0.4%3.59M after | 3 lots |
| Jul 13, 2022 (view filing)7:55 PM ET | Jul 11-13 | 2 days | Ew Healthcare Partners Fund 2, L.P. and 3 othersOther: See footnote 2 | PPurchaseCommon Stock, par value $0.001 per share | +15.0K | $8.02 | +$120.3K | +0.4%3.61M after | 3 lots |
| Jul 20, 2022 (view filing) | Jul 20 | Same day | Opaleye Management Inc.10% Owner | PPurchaseCommon Stock, par value $0.001 per share | +5.10K | $8.08 | +$41.2K | +5.4%99.2K after | 2 lots |
| Jul 21, 2022 (view filing) | Jul 21 | Same day | Opaleye Management Inc.10% Owner | PPurchaseCommon Stock, par value $0.001 per share | +10.3K | $8.03 | +$83.0K | +11.5%100.0K after | 2 lots |
| Jul 22, 2022 (view filing) | Jul 22 | Same day | Opaleye Management Inc.10% Owner | PPurchaseCommon Stock, par value $0.001 per share | +5.20K | $8.02 | +$41.7K | +5.5%100.2K after | 2 lots |
| Aug 12, 2022 (view filing) | Aug 10 | 2 days | Opaleye Management Inc.10% Owner | PPurchaseCommon Stock, par value $0.001 per share | +12.0K | $8.52 | +$102.1K | +12.9%105.0K after | 2 lots |
| Aug 12, 2022 (view filing) | Aug 1 | 11 days | Opaleye Management Inc.10% Owner | PPurchaseCommon Stock, par value $0.001 per share | +4.98K | $7.96 | +$39.6K | +5.2%100.7K after | Amended2 lots |
| Aug 16, 2022 (view filing) | Aug 16 | Same day | Opaleye Management Inc.10% Owner | PPurchaseCommon Stock, par value $0.001 per share | +315.0K | $8.00 | +$2.52M | New position120.0K after | 2 lots |
| Aug 19, 2022 (view filing)4:07 PM ET | Aug 17 | 2 days | Ew Healthcare Partners Fund 2, L.P. and 3 othersOther: See footnote 2 | PPurchaseCommon Stock, par value $0.001 per share | +500.0K | $8.00 | +$4.00M | +13.9%4.11M after | |
| Sep 15, 2022 (view filing) | Aug 16 | 30 daysLate | Opaleye Management Inc.10% Owner | PPurchaseCommon Stock, par value $0.001 per share | +5.22K | $8.10 | +$42.3K | +4.5%120.2K after | 2 lots |
| Sep 16, 2022 (view filing) | Sep 15-16 | 1 day | Opaleye Management Inc.10% Owner | PPurchaseCommon Stock, par value $0.001 per share | +6.53K | $8.09 | +$52.8K | +5.7%121.2K after | 4 lots |
| Sep 19, 2022 (view filing) | Sep 19 | Same day | Opaleye Management Inc.10% Owner | PPurchaseCommon Stock, par value $0.001 per share | +18.0K | $8.09 | +$145.6K | +17.3%122.2K after | 2 lots |
| Sep 26, 2022 (view filing) | Sep 23 | 3 days | Opaleye Management Inc.10% Owner | PPurchaseCommon Stock, par value $0.001 per share | +6.80K | $7.99 | +$54.4K | +5.9%122.6K after | 2 lots |
| Oct 11, 2022 (view filing) | Oct 11 | Same day | Opaleye Management Inc.10% Owner | PPurchaseCommon Stock, par value $0.001 per share | +16.0K | $8.00 | +$128.0K | +14.9%123.6K after | 2 lots |
| Nov 4, 2022 (view filing) | Nov 3 | 1 day | Opaleye Management Inc.10% Owner | PPurchaseCommon Stock, par value $0.001 per share | +20.3K | $7.81 | +$158.2K | +19.4%124.8K after | 2 lots |
| Apr 21, 2023 (view filing)5:08 PM ET | Apr 19-21 | 2 days | OrbiMed Advisors LLC and 1 other10% Owner | SSale | −192.0K | $9.34 | −$1.79M | −6.3%2.84M after | 3 lots |
| Nov 14, 2023 (view filing) | Nov 14 | Same day | Koblish AntonyChief Executive Officer | PPurchase | +11.0K | $4.54 | +$49.9K | +3.8%303.6K after | |
| Nov 14, 2023 (view filing) | Nov 14 | Same day | Cuca RobertoCOO and CFO | PPurchase | +10.0K | $4.49 | +$44.9K | +19.1%62.4K after | |
| Dec 7, 2023 (view filing) | Dec 5 | 2 days | Firestone Gregory A.Chief Business Officer | PPurchase | +2.60K | $5.65 | +$14.7K | +7.9%35.5K after | |
| Feb 16, 2024 (view filing)4:10 PM ET | Apr 1, 2020-Jul 14, 2022 | 1,416 daysLate | Ew Healthcare Partners Fund 2, L.P. and 3 others10% Owner, Other: See Remarks | PPurchaseCommon Stock, par value $0.001 per share | +326.1K | $9.32 | +$3.04M | +9.9%3.61M after | 27 lots |
| Jul 2, 2024 (view filing)4:54 PM ET | Jun 28-Jul 2 | 4 days | OrbiMed Advisors LLC and 1 other10% Owner | SSale | −428.3K | $4.72 | −$2.02M | −15.1%2.41M after | 3 lots |
| Oct 24, 2024 (view filing) | Oct 24 | Same day | Firestone Gregory A.Chief Commercial Officer | PPurchase | +6.67K | $2.25 | +$15.0K | +13.2%57.3K after | |
| Oct 24, 2024 (view filing) | Oct 24 | Same day | Koblish AntonyChief Executive Officer | PPurchase | +88.9K | $2.25 | +$200.0K | +24.0%458.9K after | |
| Oct 24, 2024 (view filing) | Oct 24 | Same day | Talmo PaulChief Technology Officer | PPurchase | +22.2K | $2.25 | +$50.0K | +32.3%91.1K after | |
| Oct 24, 2024 (view filing) | Oct 24 | Same day | Cuca RobertoCOO and CFO | PPurchase | +64.4K | $2.25 | +$145.0K | +70.9%155.4K after | |
| Nov 17, 2025 (view filing)4:26 PM ET | Nov 17 | Same day | Ew Healthcare Partners Fund 2, L.P. and 3 others10% Owner, Other: See Remarks | PPurchaseCommon Stock, par value $0.001 per share | +3.60M | $1.11 | +$4.00M | +87.7%7.71M after | |
| Aug 17, 2026 (view filing)4:32 PM ET | Aug 14 | 3 days | Getz Heather CChief Executive Officer | PPurchase | +15.0K | $0.6978 | +$10.5K | +3.0%520.0K after | |
| Aug 19, 2026 (view filing)4:10 PM ET | Aug 17 | 2 days | Getz Heather CChief Executive Officer | PPurchase | +12.5K | $0.6649 | +$8.31K | +2.4%532.5K after | |
| Sep 16, 2026 (view filing)6:46 PM ET | Sep 14-15 | 2 days | Capper Joseph HDirector | PPurchase | +75.0K | $1.05 | +$78.4K | +251.5%104.8K after | 2 lots |
| Sep 18, 2026 (view filing)4:30 PM ET | Sep 16-17 | 2 days | Capper Joseph HDirector | PPurchase | +75.0K | $1.18 | +$88.8K | +71.5%179.8K after | 2 lots |